- Home
- ADC vs CAI Comparison
ADC vs CAI Comparison
Compare ADC & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADC | CAI |
|---|---|---|
| Founded | 1971 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 8.0B |
| IPO Year | 1994 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ADC | CAI |
|---|---|---|
| Price | $72.44 | $24.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 7 |
| Target Price | ★ $80.65 | $34.71 |
| AVG Volume (30 Days) | 1.3M | ★ 2.2M |
| Earning Date | 02-10-2026 | 02-12-2026 |
| Dividend Yield | ★ 4.33% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.71 | N/A |
| Revenue | ★ $688,643,000.00 | $649,062,000.00 |
| Revenue This Year | $16.40 | $77.47 |
| Revenue Next Year | $10.96 | $35.87 |
| P/E Ratio | $42.38 | ★ N/A |
| Revenue Growth | 14.67 | ★ 112.02 |
| 52 Week Low | $68.98 | $22.86 |
| 52 Week High | $79.65 | $42.50 |
Technical Indicators
Market Signals| Indicator | ADC | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 52.35 | N/A |
| Support Level | $71.56 | N/A |
| Resistance Level | $71.98 | N/A |
| Average True Range (ATR) | 1.39 | 0.00 |
| MACD | 0.17 | 0.00 |
| Stochastic Oscillator | 71.46 | 0.00 |
Price Performance
Historical ComparisonAbout ADC Agree Realty Corporation
Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.
About CAI Caris Life Sciences Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.